| Acute kidney injury in COVID-19: emerging evidence of a distinct pathophysiology D Batlle, MJ Soler, MA Sparks, S Hiremath, AM South, PA Welling, ... Journal of the American Society of Nephrology 31 (7), 1380-1383, 2020 | 688 | 2020 |
| Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes M Ye, J Wysocki, J William, MJ Soler, I Cokic, D Batlle Journal of the American Society of Nephrology 17 (11), 3067-3075, 2006 | 648 | 2006 |
| ACE and ACE2 activity in diabetic mice J Wysocki, M Ye, MJ Soler, SB Gurley, HD Xiao, KE Bernstein, ... Diabetes 55 (7), 2132-2139, 2006 | 384 | 2006 |
| Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA ERACODA Working Group Duivenvoorden Raphaël Franssen Casper FM Hemmelder ... Nephrology Dialysis Transplantation 36 (1), 87-94, 2021 | 369 | 2021 |
| Characterization of ACE and ACE2 expression within different organs of the NOD mouse H Roca-Ho, M Riera, V Palau, J Pascual, MJ Soler International journal of molecular sciences 18 (3), 563, 2017 | 342 | 2017 |
| ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice MJ Soler, J Wysocki, M Ye, J Lloveras, Y Kanwar, D Batlle Kidney international 72 (5), 614-623, 2007 | 268 | 2007 |
| Recent advances in nanoplasmonic biosensors: applications and lab-on-a-chip integration GA Lopez, MC Estevez, M Soler, LM Lechuga Nanophotonics 6 (1), 123-136, 2017 | 259 | 2017 |
| Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan MJ Soler, M Ye, J Wysocki, J William, J Lloveras, D Batlle American Journal of Physiology-Renal Physiology 296 (2), F398-F405, 2009 | 231 | 2009 |
| Label-free plasmonic biosensors for point-of-care diagnostics: a review M Soler, CS Huertas, LM Lechuga Expert review of molecular diagnostics 19 (1), 71-81, 2019 | 189 | 2019 |
| Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR< 45 mL/min) Guideline Development Group, H Bilo, L Coentrão, C Couchoud, A Covic, ... Nephrology Dialysis Transplantation 30 (suppl_2), ii1-ii142, 2015 | 173 | 2015 |
| Low HDL and high triglycerides predict COVID-19 severity L Masana, E Correig, D Ibarretxe, E Anoro, JA Arroyo, C Jericó, ... Scientific reports 11 (1), 7217, 2021 | 172 | 2021 |
| How nanophotonic label-free biosensors can contribute to rapid and massive diagnostics of respiratory virus infections: COVID-19 case M Soler, MC Estevez, M Cardenosa-Rubio, A Astua, LM Lechuga ACS sensors 5 (9), 2663-2678, 2020 | 153 | 2020 |
| Angiotensin-converting enzyme 2: enhancing the degradation of angiotensin II as a potential therapy for diabetic nephropathy D Batlle, J Wysocki, MJ Soler, K Ranganath Kidney international 81 (6), 520-528, 2012 | 144 | 2012 |
| ACE2 and diabetes: ACE of ACEs? D Batlle, MJ Soler, M Ye Diabetes 59 (12), 2994, 2010 | 144 | 2010 |
| ACE2 alterations in kidney disease MJ Soler, J Wysocki, D Batlle Nephrology dialysis transplantation 28 (11), 2687-2697, 2013 | 143 | 2013 |
| Acute kidney injury in patients treated with immune checkpoint inhibitors S Gupta, SAP Short, ME Sise, JM Prosek, SM Madhavan, MJ Soler, ... Journal for immunotherapy of cancer 9 (10), 2021 | 140 | 2021 |
| A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant N Murakami, P Mulvaney, M Danesh, A Abudayyeh, A Diab, ... Kidney international 100 (1), 196-205, 2021 | 121 | 2021 |
| Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease L Anguiano, M Riera, J Pascual, JM Valdivielso, C Barrios, A Betriu, ... Nephrology Dialysis Transplantation 30 (7), 1176-1185, 2015 | 118 | 2015 |
| GLP-1 receptor agonists and diabetic kidney disease: a call of attention to nephrologists JL Górriz, MJ Soler, JF Navarro-González, C García-Carro, MJ Puchades, ... Journal of clinical medicine 9 (4), 947, 2020 | 117 | 2020 |
| ADAM17 inhibition may exert a protective effect on COVID-19 V Palau, M Riera, MJ Soler Nephrology Dialysis Transplantation 35 (6), 1071-1072, 2020 | 116 | 2020 |
Juan F. Navarro-GonzálezHospital Universitario Nuestra Señora de CandelariaVerified email at gobiernodecanarias.org
